9996 Stock Overview
Engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Peijia Medical Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$2.33 |
52 Week High | HK$9.80 |
52 Week Low | HK$2.16 |
Beta | 0.54 |
11 Month Change | 2.19% |
3 Month Change | n/a |
1 Year Change | -73.52% |
33 Year Change | -92.48% |
5 Year Change | n/a |
Change since IPO | -90.97% |
Recent News & Updates
Risks Still Elevated At These Prices As Peijia Medical Limited (HKG:9996) Shares Dive 30%
Jul 17More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%
Mar 28Recent updates
Risks Still Elevated At These Prices As Peijia Medical Limited (HKG:9996) Shares Dive 30%
Jul 17More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%
Mar 28More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 29%
Jan 22Estimating The Intrinsic Value Of Peijia Medical Limited (HKG:9996)
Dec 05Does Peijia Medical (HKG:9996) Have A Healthy Balance Sheet?
Oct 22Calculating The Fair Value Of Peijia Medical Limited (HKG:9996)
Aug 04Is Peijia Medical (HKG:9996) A Risky Investment?
May 29Getting In Cheap On Peijia Medical Limited (HKG:9996) Is Unlikely
May 10Are Investors Undervaluing Peijia Medical Limited (HKG:9996) By 40%?
Jan 17Despite Lacking Profits Peijia Medical (HKG:9996) Seems To Be On Top Of Its Debt
Oct 05A Look At The Fair Value Of Peijia Medical Limited (HKG:9996)
Aug 29We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely
Mar 16We Think Peijia Medical (HKG:9996) Can Easily Afford To Drive Business Growth
Nov 26We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely
Jul 30Is Peijia Medical Limited (HKG:9996) Worth HK$28.3 Based On Its Intrinsic Value?
May 05Could The Peijia Medical Limited (HKG:9996) Ownership Structure Tell Us Something Useful?
Mar 03Peijia Medical Limited's (HKG:9996) Intrinsic Value Is Potentially 43% Above Its Share Price
Jan 27We Think Peijia Medical (HKG:9996) Can Afford To Drive Business Growth
Dec 23Shareholder Returns
9996 | HK Medical Equipment | HK Market | |
---|---|---|---|
7D | -13.1% | -2.5% | -1.9% |
1Y | -73.5% | -52.8% | -6.7% |
Return vs Industry: 9996 underperformed the Hong Kong Medical Equipment industry which returned -52.8% over the past year.
Return vs Market: 9996 underperformed the Hong Kong Market which returned -6.7% over the past year.
Price Volatility
9996 volatility | |
---|---|
9996 Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.9% |
Market Average Movement | 6.7% |
10% most volatile stocks in HK Market | 14.1% |
10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 9996's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9996's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 973 | Yi Zhang | www.peijiamedical.com |
Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde crosslinking dry-tissue TAVR system; TaurusMax, an iteration steerable TAVR system; TaurusTrio, a TAVR system; TaurusWave, a lithotripsy valvuloplasty system; TaurusApex, a polymeric leaflet TAVR system; Trilogy, a TAVR System; HighLife, a transseptal mitral value replacement system; Sutra Hemi Valve, a TMV coaptation augmentation system; GeminiOne, a transcatheter edge-to-edge repair system; MonarQ which is transcatheter tricuspid valve replacement systems; TaurusAtlas, a transfemoral balloon catheter; TaurusExplora, a pre-shaped guidewire; and TaurusNavi, an introducer sheath. The company also offers Jasper and Presgo, that are detachable coils; Jasper SS detachable coil; intracranial adjunctive stents; SacSpeed, a balloon dilatation catheter; Tethys AS, an aspiration catheter; Syphonet, a stent retriever; Fastunnel, a balloon microcatheter; Fluxcap, a balloon guiding catheter; NeuroStellar, an intracranial stent; Presgo microcatheter and micro guidewire; Heralder guiding catheter and distal access catheter; Tethys, an intermediate catheter; and Jasper power supply.
Peijia Medical Limited Fundamentals Summary
9996 fundamental statistics | |
---|---|
Market cap | HK$1.57b |
Earnings (TTM) | -HK$422.45m |
Revenue (TTM) | HK$474.76m |
3.3x
P/S Ratio-3.7x
P/E RatioIs 9996 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9996 income statement (TTM) | |
---|---|
Revenue | CN¥441.13m |
Cost of Revenue | CN¥115.76m |
Gross Profit | CN¥325.37m |
Other Expenses | CN¥717.90m |
Earnings | -CN¥392.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.58 |
Gross Margin | 73.76% |
Net Profit Margin | -88.98% |
Debt/Equity Ratio | 9.6% |
How did 9996 perform over the long term?
See historical performance and comparison